Beauty Industry

J&J Allowed to Resume Manufacturing in India

This comes after the Maharashtra Food and Drug Administration had ordered the company to stop manufacturing baby powder.

The Bombay High Court has allowed Johnson & Johnson to resume manufacturing of baby powder at its Mulund plant, which has been ordered to stop by the Maharashtra Food and Drug Administration.

J&J offered test batches, and no carcinogens were found.

A J&J spokesperson commented, “Nothing is more important to us than the well-being of consumers, and we see this outcome as a significant step in restoring their confidence. We will continue to work closely with Maharashtra FDA, and provide India with safe, high quality products that help people care for themselves and their families.”

Add us as a preferred source on Google

Get the latest Beauty Packaging news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Beauty Packaging Newsletters